Shandong Boyuan Pharmaceutical & Chemical Co. Ltd.

  • Market Cap: Small Cap
  • Industry: Specialty Chemicals
  • ISIN: CNE100006QR2
CNY
65.33
1.17 (1.82%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Net Sales
1,462.68
1,323.50
1,021.43
795.85
522.24
Other Operating Income
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,462.68
1,323.50
1,021.43
795.85
522.24
Raw Material Cost
1,178.71
1,007.09
746.64
523.57
350.89
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
Employee Cost
85.36
86.18
51.10
41.11
29.50
Power Cost
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.32
0.50
0.30
0.90
2.10
Selling and Distribution Expenses
43.74
36.13
35.53
32.63
27.52
Other Expenses
-3.67
-4.68
-1.75
-1.35
-1.17
Total Expenditure (Excl Depreciation)
1,271.42
1,083.14
816.10
584.72
398.27
Operating Profit (PBDIT) excl Other Income
191.29999999999998
240.39999999999998
205.3
211.1
124
Other Income
1.96
1.40
0.27
-4.76
-3.40
Operating Profit (PBDIT)
231.00
274.14
233.44
228.28
139.67
Interest
0.32
0.50
0.30
0.90
2.10
Exceptional Items
0.01
0.00
-0.15
-3.19
0.00
Gross Profit (PBDT)
283.96
316.42
274.79
272.28
171.35
Depreciation
34.72
29.28
25.11
22.88
19.88
Profit Before Tax
195.97
244.36
207.88
201.31
117.69
Tax
23.68
31.52
25.78
24.99
14.40
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
Profit After Tax
172.29
212.84
182.10
176.32
103.29
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
Net Profit
172.29
212.84
182.10
176.32
103.29
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
172.29
212.84
182.10
176.32
103.29
Equity Capital
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
Reserves
1,728.73
1,656.65
808.58
627.49
450.26
Earnings per share (EPS)
1.29
1.59
1.36
1.32
0.77
Diluted Earnings per share
1.29
1.59
1.36
1.32
0.77
Operating Profit Margin (Excl OI)
13.29%
18.4%
20.37%
26.41%
23.59%
Gross Profit Margin
15.77%
20.68%
22.81%
28.17%
26.34%
PAT Margin
11.78%
16.08%
17.83%
22.16%
19.78%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 10.52% vs 29.58% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is -19.03% vs 16.86% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is -16.02% vs 16.94% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is -40.00% vs 66.67% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has fallen from Dec 2024

Compare Annual Results Of Shandong Boyuan Pharmaceutical & Chemical Co. Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
1,462.68
0
1,462.68
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,462.68
0
1,462.68
Raw Material Cost
1,178.71
0
1,178.71
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
85.36
0
85.36
Power Cost
0
0
0.00
Manufacturing Expenses
0.32
0
0.32
Selling and Distribution Expenses
43.74
0
43.74
Other Expenses
-3.67
0.00
-3.67
Total Expenditure (Excl Depreciation)
1,271.42
0
1,271.42
Operating Profit (PBDIT) excl Other Income
191.25
0.00
191.25
Other Income
1.96
0
1.96
Operating Profit (PBDIT)
231.00
0
231.00
Interest
0.32
0
0.32
Exceptional Items
0.01
0
0.01
Gross Profit (PBDT)
283.96
0
283.96
Depreciation
34.72
0
34.72
Profit Before Tax
195.97
0
195.97
Tax
23.68
0
23.68
Provisions and contingencies
0
0
0.00
Profit After Tax
172.29
0
172.29
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
172.29
0
172.29
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
172.29
0
172.29
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,728.73
0
1,728.73
Earnings per share (EPS)
1.29
0
1.29
Diluted Earnings per share
1.29
0
1.29
Operating Profit Margin (Excl OI)
13.29%
0%
0.00
13.29%
Gross Profit Margin
15.77%
0%
0.00
15.77%
PAT Margin
11.78%
0%
0.00
11.78%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 146.27 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 10.52% vs 29.58% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 17.23 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -19.03% vs 16.86% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 22.90 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -16.02% vs 16.94% in Dec 2024

Annual - Interest
Interest 0.03 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -40.00% vs 66.67% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.29%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has fallen from Dec 2024